Pravastatin
Panchol, Pravastatin · ATC code C10AA03
Brand names: Panchol, Prava-Teva, Prava-Teva®, Pavas, Pravachol, Uprast
- Key facts
- Active substance
- Pravastatin
- ATC code
- C10AA03
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-29
Key facts
Pravastatin is an HMG-CoA reductase inhibitor (statin). Per the US prescribing information, it is used to lower LDL cholesterol and to reduce the risk of cardiovascular events in adults with or without coronary heart disease, and in children with familial hypercholesterolemia.
What it is used for
- Reduction of the risk of myocardial infarction, revascularization and cardiovascular death in adults with elevated LDL-C without evident coronary heart disease
- Reduction of coronary death, myocardial infarction, revascularization, stroke/TIA and slowing of coronary atherosclerosis in adults with evident CHD
- Adjunct to diet in primary hyperlipidemia, primary dysbetalipoproteinemia and hypertriglyceridemia in adults
- Heterozygous familial hypercholesterolemia in children aged 8 years and older
Dosing
- Adults: 40 mg to 80 mg once daily at any time, with or without food; check LDL-C as early as 4 weeks after starting
- Children 8 to 13 years: 20 mg once daily; 14 to 18 years: starting dose 40 mg once daily
- Severe renal impairment: start 10 mg once daily, maximum 40 mg once daily
- Cyclosporine: start 10 mg, maximum 20 mg once daily; clarithromycin or erythromycin: maximum 40 mg once daily
- Bile acid sequestrants: take pravastatin at least 1 hour before or 4 hours after
Contraindications
- Acute liver failure or decompensated cirrhosis
- Hypersensitivity to pravastatin or any excipient
Important warnings
- Myopathy and rhabdomyolysis, rarely fatal; risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, certain drugs and higher doses
- Immune-mediated necrotizing myopathy (rare)
- Hepatic dysfunction: transaminase increases; stop if serious liver injury or jaundice occurs
- Increases in HbA1c and fasting serum glucose
Side effects
- Reported in ≥ 2% and more often than placebo: nausea/vomiting (7.4%), diarrhea (6.7%), headache (6.3%), upper respiratory infection, angina pectoris and rash (4.5% each)
- Also: CK increase, dizziness, ALT increase, chest pain, cough, myalgia
- Serious: rhabdomyolysis, liver injury
Interactions
- Gemfibrozil: avoid
- Cyclosporine, clarithromycin, erythromycin: dose limits
- Niacin, fibrates and colchicine: increased myopathy risk
- Bile acid sequestrants: separate dosing
Pregnancy and breastfeeding
- May cause fetal harm; discontinue when pregnancy is recognized, or consider the individual patient's needs
- Present in human milk
Summary of the official product information, written with AI on 2026-10-29. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- PancholG.L. Pharma Gmbh · 1 register entry
- Pravastatin1a Pharma Gmbh, Teva B.V, Sandoz Gmbh, Stada Arzneimittel Gmbh · 5 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29
Germany
- Prava-TevaTeva Gmbh · 1 register entry
- Prava-Teva®Teva Gmbh · 1 register entry
- Pravastatin1 A Pharma Gmbh, Ratiopharm Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Holsten Pharma Gmbh, Axunio Pharma Gmbh, Hexal Ag, Stadapharm Gmbh, Abz-Pharma Gmbh, Aliud Pharma Gmbh · 10 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29
Turkey
- PavasNOBEL İLAÇ SAN. VE TİC. A.Ş. · 16 register entries
- PravacholDEVA HOLDİNG A.Ş. · 3 register entries
- UprastULKAR İLAÇ PAZARLAMA LTD. ŞTİ. · 16 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 17 more European countries
- Belgium
- Prareduct, Pravastatin Ab, Pravastatine Eg, Pravastatine Sandoz, Pravastatine Teva, Pravastatine Viatris
- Cyprus
- Lipren
- Denmark
- Pravastatin Sandoz, Pravastatin Stada, Pravastatinnatrium Teva
- Estonia
- Pravahexal
- Finland
- Pravastatin Orion, Pravastatin Ratiopharm
- France
- Pravastatine Accord, Pravastatine Almus, Pravastatine Arrow, Pravastatine Biogaran, Pravastatine Cristers, Pravastatine Eg, Pravastatine Evolugen Pharma, Pravastatine Sandoz, Pravastatine Teva, Pravastatine Viatris, Pravastatine Zentiva, Pravastatine Zydus
- Greece
- Analipin, Asto-Chol, Lipoprav, Maxudin, Pravahelp, Pravalip, Pravalong, Pravanox, Pravin, Sosmin
- Ireland
- Pravamel, Pravastatin Sodium Norton Waterford, Pravastatin Viatris, Pravitin
- Italy
- Aplactin, Langiprav, Prasterol, Pravaselect, Pravastatina Almus, Pravastatina Alter, Pravastatina Aurobindo, Pravastatina Doc Generici, Pravastatina Eg, Pravastatina Mylan, Pravastatina Ratiopharm, Pravastatina Sandoz Gmbh, Pravastatina Zentiva, Setac, Vasticor
- Luxembourg
- Prareduct, Pravastatine Eg
- Malta
- Pravastatin Sodium Aurobindo
- Netherlands
- Pravastatin Na Stada, Pravastatine Na Cf, Pravastatine Na Stada, Pravastatinenatrium Accord, Pravastatinenatrium Aurobindo, Pravastatinenatrium Doc Generici, Pravastatinenatrium Pharmachemie, Pravastatinenatrium Ratiopharm, Pravastatinenatrium Sandoz, Pravastatinenatrium Teva, Pravastatinenatrium Viatris
- Norway
- Pravastatin Sandoz, Pravastatin Teva
- Portugal
- Bluesar, Placir, Pravastatina Alter, Pravastatina Aurobindo, Pravastatina Aurovitas, Pravastatina Bluepharma, Pravastatina Ciclum, Pravastatina Generis, Pravastatina Jaba, Pravastatina Mylan, Pravastatina Pharmakern, Pravastatina Ratiopharm, Pravastatina Sandoz, Pravastatina Tetrafarma, Pravastatina Teva, Pravastatina Tolife, Pravastatina Zentiva
- Slovenia
- Pravastatin Teva
- Spain
- Liplat, Pravastatina Almus, Pravastatina Alter, Pravastatina Aurovitas, Pravastatina Cinfamed, Pravastatina Codramol Farmalider, Pravastatina Davur, Pravastatina Kern Pharma, Pravastatina Korhispana, Pravastatina Mabo, Pravastatina Normon, Pravastatina Pharma Combix, Pravastatina Qualigen, Pravastatina Sandoz, Pravastatina Stada, Pravastatina Tarbis, Pravastatina Tecnigen, Pravastatina Teva-Ratio, Pravastatina Viatris, Pravastatina Vir, Pritadol
- Sweden
- Pravastatin Sandoz, Pravastatin Teva
EMA – Article 57 product data (EU/EEA), 2026-10-29
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Related calculators
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Pravastatin sodium (Aurobindo Pharma Limited) – Prescribing Information, 2026-07-29. DailyMed (NLM), 2026-10-29. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b06ed801-ddee-4f56-924a-59fcb451eae6
- EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-10-29 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.